4//SEC Filing
Cvijic Christine Mikail 4
Accession 0001404644-25-000007
CIK 0001404644other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:14 PM ET
Size
6.1 KB
Accession
0001404644-25-000007
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Cvijic Christine Mikail
President and CFO
Transactions
- Sale
Common Stock
2025-03-13$16.94/sh−4,501$76,247→ 72,343 total
Footnotes (3)
- [F1]On March 12, 2024, a Restricted Stock Unit (RSU) held by the Reporting Person vested in part. The shares issuable on vesting of the RSU are reported as shares held by the Reporting Person. The award agreement for the RSU provides that the Registrant shall sell a number of shares necessary to cover the Reporting Person's tax withholding responsibility created by the vesting event, with no election made by the Reporting Person. The sale reported on this Form 4 relates exclusively to this mandatory sale upon vesting of the RSU.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.38 to $17.21, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 24,000 shares held jointly by the reporting person and her spouse, David Cvijic.
Documents
Issuer
Neurogene Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001543663
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:14 PM ET
- Size
- 6.1 KB